Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Join in our 50K Contest

Site Tools

  • AAAS
  • Subscribe
  • Feedback

Site Search

Search Advanced

Science 5 November 1999:
Vol. 286. no. 5442, pp. 1058 - 1059
DOI: 10.1126/science.286.5442.1058

News of the Week

MOLECULAR BIOLOGY:
EMBL Faces Huge Bill Following Adverse Pay Dispute Ruling

Michael Balter

An adverse judgment in a salary dispute could wipe out as much as 25% of the core funding of the European Molecular Biology Laboratory (EMBL) in Heidelberg, Germany, and threaten cancellation of its ambitious future plans. The bad news was delivered at a staff meeting last month by EMBL director-general Fotis Kafatos, who told researchers and other employees that a worst-case interpretation of the ruling could lead to the institution shutting down. Although Kafatos stressed that this possibility was remote, even under the most optimistic interpretation the complex judgment will cost the lab millions of dollars in back salary payments and possibly curtail important new research initiatives.

Read the Full Text





ADVERTISEMENT
Click Me!

ADVERTISEMENT
Click Me!

To Advertise     Find Products


Science. ISSN 0036-8075 (print), 1095-9203 (online)